Josh Cotts is a Senior Contributor at Game Rant. He graduated Summa Cum Laude from Arizona State University in 2019 with a B.A. in Mass Communications & Media Studies and has been commended since ...

At the start of Octopath Traveler 0, you can pick from 8 different jobs for your Protagonist. The Protagonist Jobs offer you ...

An avid gamer with over 30 years of experience, there aren't many consoles that Dan hasn't owned at some point in his life. He's also part Italian, which means he's almost certainly related to Super ...

The original protagonist gives players the game’s original experience. When choosing protagonists, the game even encourages newcomers to choose the male protagonist because he’s usually considered the ...

This article contains Tenet spoilers. The Protagonist might be one of the most unimaginatively named main characters of all time, but it’s worth pointing out that he is referred to as “the Protagonist ...

One of the most interesting parts of anime and shonen protagonists is how many of them seem to share similar traits. Especially within battle series, a vast majority of shonen main characters seem to ...

GameSpot may get a commission from retail offers. Starfield's protagonist is not voiced, but that wasn't always the case. In pre-production, Bethesda Game Studios wanted to have a voiced protagonist, ...

Rachel Sandell is an experienced editor and proofreader with a love for language and storytelling. A graduate of the creative writing MFA program, The Rainier Writing Workshop, she is the author of ...

Meet Dev, an avid writer, cat lover, and anime enthusiast. He has a passion for storytelling, traveling, and new adventures. Explore the world of shonen anime through our handpicked selection ...

Takeda has bolstered its near-term pipeline in rare haematological disorders by licensing rights to a polycythaemia vera (PV) treatment being developed by Protagonist Therapeutics. The Japanese pharma ...

A hero has arrived in Protagonist Therapeutics’ story, in the form of a Johnson & Johnson-partnered psoriasis med that has just cleared lesions in a mid-stage trial. JNJ-2113, previously known as ...

Protagonist Therapeutics' stock has experienced significant volatility over the past three years, with multiple setbacks and recoveries. The company's lead drug candidate, Rusfertide, indicated for ...